Search Results - "LoRusso, Patricia"

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Lopez, Juanita, Powles, Thomas, Braiteh, Fadi, Siu, Lillian L., LoRusso, Patricia, Friedman, Claire F., Balmanoukian, Ani S., Gordon, Michael, Yachnin, Jeffrey, Rottey, Sylvie, Karydis, Ioannis, Fisher, George A., Schmidt, Marcus, Schuler, Martin, Sullivan, Ryan J., Burris, Howard A., Galvao, Vladimir, Henick, Brian S., Dirix, Luc, Jaeger, Dirk, Ott, Patrick A., Wong, Kit Man, Jerusalem, Guy, Schiza, Aglaia, Fong, Lawrence, Steeghs, Neeltje, Leidner, Rom S., Rittmeyer, Achim, Laurie, Scott A., Gort, Eelke, Aljumaily, Raid, Melero, Ignacio, Sabado, Rachel L., Rhee, Ina, Mancuso, Michael R., Muller, Lars, Fine, Gregg D., Yadav, Mahesh, Kim, Leesun, Leveque, Vincent J. P., Robert, Alberto, Darwish, Martine, Qi, Ting, Zhu, Jiawen, Zhang, Jingbin, Twomey, Patrick, Rao, Gautham K., Low, Donald W., Petry, Chris, Lo, Amy A., Schartner, Jill M., Delamarre, Lelia, Mellman, Ira, Loewer, Martin, Mueller, Felicitas, Derhovanessian, Evelyna, Cortini, Andrea, Manning, Luisa, Maurus, Daniel, Brachtendorf, Sebastian, Loerks, Verena, Omokoko, Tana, Godehardt, Eva, Becker, Dirk, Hawner, Christine, Wallrapp, Christine, Albrecht, Christian, Kroener, Christoph, Tadmor, Arbel D., Diekmann, Jan, Vormehr, Mathias, Jork, Anette, Paruzynski, Anna, Lang, Maren, Blake, Jonathon, Hennig, Oliver, Kuhn, Andreas N., Sahin, Ugur, Tureci, Ozlem, Camidge, D. Ross

electronic

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study: Clinical Studies

Yap, Timothy A.^{Aff1, IDs4141602503053x_cor1}, LoRusso, Patricia, Miller, Rowan E., Kristeleit, Rebecca, Paulovich, Amanda G., McMorn, Stephen, Oplustil O’Connor, Lenka, Lombardi, Benedetta, Marco-Casanova, Paola, Gangl, Eric T., Patel, Bharat, O’Connor, Mark J., Dean, Emma, Zviezdin, Roman, Plummer, Ruth

Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.

Mukohara, Toru, Park, Yeon, Sommerhalder, David, Yonemori, Kan, Hamilton, Erika, Kim, Sung-Bae, Kim, Jee, Iwata, Hiroji, Yamashita, Toshinari, Layman, Rachel, Mita, Monica, Clay, Timothy, Chae, Yee, Oakman, Catherine, Yan, Fengting, Kim, Gun, Im, Seock-Ah, Lindeman, Geoffrey, Rugo, Hope, Liyanage, Marlon, Saul, Michelle, Le Corre, Christophe, Skoura, Athanasia, Liu, Li, Li, Meng, LoRusso, Patricia

application/pdf

A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).

Maldonado, Edward, Rathmell, W, Shapiro, Geoffrey, Takebe, Naoko, Rodon, Jordi, Mahalingam, Devalingam, Trikalinos, Nikolaos, Kalebasty, Arash, Parikh, Mamta, Boerner, Scott, Balido, Celene, Krings, Gregor, Burns, Timothy, Bergsland, Emily, Munster, Pamela, Ashworth, Alan, LoRusso, Patricia, Aggarwal, Rahul

application/pdf

NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma

Cecchini, Michael, Cleary, James M, Shyr, Yu, Chao, Joseph, Uboha, Nataliya, Cho, May, Shields, Anthony, Pant, Shubham, Goff, Laura, Spencer, Kristen, Kim, Edward, Stein, Stacey, Kortmansky, Jeremy S, Canosa, Sandra, Sklar, Jeffrey, Swisher, Elizabeth M, Radke, Marc, Ivy, Percy, Boerner, Scott, Durecki, Diane E, Hsu, Chih-Yuan, LoRusso, Patricia, Lacy, Jill

application/pdf

The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results

Lewis, Gail D.^{Aff1, IDs4146702344533z_cor1}, Li, Guangmin, Guo, Jun, Yu, Shang-Fan, Fields, Carter T., Lee, Genee, Zhang, Donglu, Dragovich, Peter S., Pillow, Thomas, Wei, BinQing, Sadowsky, Jack^{Aff7, Aff21}, Leipold, Douglas, Wilson, Tim, Kamath, Amrita, Mamounas, Michael, Lee, M. Violet, Saad, Ola, Choeurng, Voleak, Ungewickell, Alexander, Monemi, Sharareh, Crocker, Lisa, Kalinsky, Kevin, Modi, Shanu, Jung, Kyung Hae, Hamilton, Erika, LoRusso, Patricia, Krop, Ian, Schutten, Melissa M.^{Aff19, Aff22}, Commerford, Renee^{Aff13, Aff23}, Sliwkowski, Mark X., Cho, Eunpi

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

Roussos Torres, Evanthia.T.^{Aff1, Aff2, IDs4301802400729w_cor1}, Ho, Won J., Danilova, Ludmila, Tandurella, Joseph A., Leatherman, James, Rafie, Christine^{Aff1, Aff3}, Wang, Chenguang, Brufsky, Adam, LoRusso, Patricia, Chung, Vincent, Yuan, Yuan, Downs, Melinda, O’Connor, Ashley, Shin, Sarah M., Hernandez, Alexei, Engle, Elizabeth L., Piekarz, Richard, Streicher, Howard, Talebi, Zahra, Rudek, Michelle A., Zhu, Qingfeng, Anders, Robert A., Cimino-Mathews, Ashley, Fertig, Elana J., Jaffee, Elizabeth M., Stearns, Vered, Connolly, Roisin M.^{Aff1, Aff10, IDs4301802400729w_cor27}

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Champiat, Stephane ^{1, 13, 15, ∗}, Garralda, Elena ², Galvao, Vladimir ², Cassier, Philippe A. ³, Gomez-Roca, Carlos ⁴, Korakis, Iphigenie ⁴, Grell, Peter ⁵, Naing, Aung ⁶, LoRusso, Patricia ⁷, Mikyskova, Romana ⁸, Podzimkova, Nada ⁹, Reinis, Milan ⁸, Ouali, Kaissa ¹, Schoenenberger, Andreu ⁹, Kiemle-Kallee, Joachim ¹⁰, Tillmanns, Sascha ¹⁰, Sachse, Richard ¹⁰, Moebius, Ulrich ⁹, Spisek, Radek ⁹, Bechard, David ¹¹, Jelinkova, Lenka Palova ^{9, 12, 14}, Adkins, Irena ^{9, 12, 14}, Marabelle, Aurelien ^{1, 14}

Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.

Budhraja, Karan, McDonald, Bradon, Stephens, Michelle, Contente-Cuomo, Tania, Markus, Havell, Farooq, Maria, Favaro, Patricia, Connor, Sydney, Byron, Sara, Egan, Jan, Ernst, Brenda, McDaniel, Timothy, Sekulic, Aleksandar, Tran, Nhan, Prados, Michael, Borad, Mitesh, Berens, Michael, Pockaj, Barbara, LoRusso, Patricia, Bryce, Alan, Trent, Jeffrey, Murtaza, Muhammed

application/pdf

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Desai, Jayesh^{Aff1, IDs41591023026968_cor1}, Alonso, Guzman, Kim, Se Hyun, Cervantes, Andres, Karasic, Thomas, Medina, Laura, Shacham-Shmueli, Einat, Cosman, Rasha, Falcon, Alejandro, Gort, Eelke, Guren, Tormod, Massarelli, Erminia, Miller, Jr., Wilson H., Paz-Ares, Luis, Prenen, Hans, Amatu, Alessio, Cremolini, Chiara, Kim, Tae Won, Moreno, Victor, Ou, Sai-Hong I., Passardi, Alessandro, Sacher, Adrian, Santoro, Armando, Stec, Rafal^{Aff24, Aff25}, Ulahannan, Susanna^{Aff26, Aff27}, Arbour, Kathryn, Lorusso, Patricia, Luo, Jia, Patel, Manish R., Choi, Yoonha, Shi, Zhen, Mandlekar, Sandhya, Lin, Mark T., Royer-Joo, Stephanie, Chang, Julie, Jun, Tomi, Dharia, Neekesh V., Schutzman, Jennifer L., Han, Sae-Won^{Aff33, IDs41591023026968_cor40}

Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.

Boni, Valentina, Fidler, Mary, Arkenau, Hendrik-Tobias, Spira, Alexander, Meric-Bernstam, Funda, Uboha, Nataliya, Sanborn, Rachel, Sweis, Randy, LoRusso, Patricia, Garcia-Corbacho, Javier, Jalal, Shadia, Harding, James, Kim, Stella, Miedema, Iris, Vugts, Danielle, Huisman, Marc, Zwezerijnen, Gerben, van Dongen, Guus, Menke van der Houven van Oordt, C, Wang, Song, Dang, Tam, Zein, Ivan, Vasiljeva, Olga, Lyman, Susan, Paton, Virginia, Hannah, Alison, Liu, Joyce, Nagasaka, Misako

application/pdf

Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial

Mukohara, Toru, Park, Yeon Hee, Sommerhalder, David, Yonemori, Kan, Hamilton, Erika, Kim, Sung-Bae, Kim, Jee Hyun, Iwata, Hiroji, Yamashita, Toshinari, Layman, Rachel M., Mita, Monica, Clay, Timothy, Chae, Yee Soo, Oakman, Catherine, Yan, Fengting, Kim, Gun Min, Im, Seock-Ah, Lindeman, Geoffrey J., Rugo, Hope S., Liyanage, Marlon, Saul, Michelle, Le Corre, Christophe, Skoura, Athanasia, Liu, Li, Li, Meng^{Aff22, IDs4159102403129w_cor25}, LoRusso, Patricia M.^{Aff23, IDs4159102403129w_cor26}

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors

Bendell, Johanna^{Aff1, Aff17, IDs00262023034306_cor1}, LoRusso, Patricia, Overman, Michael, Noonan, Anne M., Kim, Dong-Wan, Strickler, John H., Kim, Sang-We, Clarke, Stephen, George, Thomas J., Grimison, Peter S., Barve, Minal, Amin, Manik^{Aff12, Aff18}, Desai, Jayesh, Wise-Draper, Trisha, Eck, Steven, Jiang, Yu, Khan, Anis A., Wu, Yuling, Martin, Philip, Cooper, Zachary A., Elgeioushi, Nairouz, Mueller, Nancy, Kumar, Rakesh, Patel, Sandip Pravin

A pilot study of volumetric and density tumor analysis of ACC patients treated with vorinostat in a phase II clinical trial

Malarkey, Molly ^a, Toscano, Alex P. ^a, Bagheri, Mohammad Hadi ^b, Solomon, Jeffrey ^c, Machado, Laura B. ^d, LoRusso, Patricia ^e, Chen, Alice ^f, Folio, Les R. ^{g, h, i}, Goncalves, Priscila H. ^{j, ∗}

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies

Falchook, Gerald, Rosen, Seth, LoRusso, Patricia, Watts, Justin, Gupta, Shilpa, Coombs, Catherine C, Talpaz, Moshe, Kurzrock, Razelle, Mita, Monica, Cassaday, Ryan, Harb, Wael, Peguero, Julio, Smith, David C, Piha-Paul, Sarina A, Szmulewitz, Russ, Noel, Marcus S, Yeleswaram, Swamy, Liu, Phillip, Switzky, Julie, Zhou, Gongfu, Zheng, Fred, Mehta, Amitkumar

application/pdf

Phase I trials as valid therapeutic options for patients with cancer

Adashek, Jacob J, LoRusso, Patricia M, Hong, David S, Kurzrock, Razelle

application/pdf

This result is not displayed to guests.
Login for full access.